In the context of ER- breast cancer, the expression of AR and its interaction with GATA3 likely promotes a more differentiated luminal phenotype, explaining why AR-ER- breast cancers represent the most aggressive, undifferentiated breast cancer subtype. The gene discussed is ESR1; the disease is breast cancer.